Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders. | Front Immunol | 2022 | 36119097 | PubTator, text mining | PubMed |
| Distinct sex-specific DNA methylation differences in Alzheimer's disease. | Alzheimers Res Ther | 2022 | 36109771 | PubTator, text mining | PubMed |
| Study of Health in Primary Care of the Amazonas Population: Protocol for an Observational Study on Diabetes Management in Brazil. | JMIR Res Protoc | 2022 | 36107477 | PubTator, text mining | PubMed |
| Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine. | EBioMedicine | 2022 | 36099812 | PubTator, text mining | PubMed |
| Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability. | Front Oncol | 2022 | 36091172 | PubTator, text mining | PubMed |
| Precise somatic genome editing for treatment of inborn errors of immunity. | Front Immunol | 2022 | 36091069 | PubTator, text mining | PubMed |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. | Br J Cancer | 2022 | 36088510 | PubTator, text mining | PubMed |
| A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer. | Front Immunol | 2022 | 36081518 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome. | Cancers (Basel) | 2022 | 36077770 | PubTator, text mining | PubMed |
| The Molecular Predictive and Prognostic Biomarkers in Metastatic Breast Cancer: The Contribution of Molecular Profiling. | Cancers (Basel) | 2022 | 36077738 | PubTator, text mining | PubMed |
| Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data? | Cancers (Basel) | 2022 | 36077726 | PubTator, text mining | PubMed |
| LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors. | Int J Mol Sci | 2022 | 36077354 | PubTator, text mining | PubMed |
| Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaks. | Nat Commun | 2022 | 36075911 | PubTator, text mining | PubMed |
| MAD2L2 promotes replication fork protection and recovery in a shieldin-independent and REV3L-dependent manner. | Nat Commun | 2022 | 36075897 | PubTator, text mining | PubMed |
| A Narrative Review on Fanconi Anemia: Genetic and Diagnostic Considerations. | Glob Med Genet | 2022 | 36071913 | PubTator, text mining | PubMed |
| Organism-specific differences in the binding of ketoprofen to serum albumin. | IUCrJ | 2022 | 36071810 | PubTator, text mining | PubMed |
| Genomic selection using random regressions on known and latent environmental covariates. | Theor Appl Genet | 2022 | 36066596 | PubTator, text mining | PubMed |
| de novo variant calling identifies cancer mutation signatures in the 1000 Genomes Project. | Hum Mutat | 2022 | 36054329 | PubTator, text mining | PubMed |
| Downregulation of circ-ZNF644 alleviates LPS-induced HK2 cell injury via miR-335-5p/HIPK1 axis. | Environ Toxicol | 2022 | 36052886 | PubTator, text mining | PubMed |
| Native glycosylation and binding of the antidepressant paroxetine in a low-resolution crystal structure of human myeloperoxidase. | Acta Crystallogr D Struct Biol | 2022 | 36048150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=39